TP53 and neoplasm: In sebaceous carcinoma, SESN2 was found to be significantly downregulated as a result of p53 mutations, and low SESN2 expression correlated with poor tumour differentiation, which is an indicator of tumour aggressiveness and poor prognosis [77].